U-Blot® Research Grade TalizumabCat. No. WA3604Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade TalizumabCat. No. WA3604U-Blot® Research Grade Taldefgrobep alfaCat. No. WA3603Request quote
Size: 50ug/100ug
U-Blot® Research Grade TalacotuzumabCat. No. WA3602Request quote
Size: 50ug/100ug
U-Blot® Research Grade tagmokitugCat. No. WA3601Request quote
Size: 50ug/100ug
U-Blot® Research Grade TagitanlimabCat. No. WA3600Request quote
Size: 50ug/100ug
U-Blot® Research Grade TafolecimabCat. No. WA3599Request quote
Size: 50ug/100ug
U-Blot® Research Grade TafasitamabCat. No. WA3598Request quote
Size: 50ug/100ug
U-Blot® Research Grade TadocizumabCat. No. WA3597Request quote
Size: 50ug/100ug
U-Blot® Research Grade TacatuzumabCat. No. WA3596Request quote
Size: 50ug/100ug
U-Blot® Research Grade TabituximabCat. No. WA3595Request quote
Size: 50ug/100ug
U-Blot® Research Grade tabirafusp alfaCat. No. WA3594Request quote
Size: 50ug/100ug
U-Blot® Research Grade TabalumabCat. No. WA3593Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598